American biotech firm Moderna said on May 26 (2021) that clinical trials have shown that its Covid-19 vaccine is “highly effective” in adolescents aged 12 to 17 years old.
The company will seek healthcare regulators’ approval next month (June 2021).
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
